Background: According to the Chinese guidelines for lipid management (2023), evolocumab in combination with statins was recommended as secondary prevention of cardiovascular disease. However, because of the variation in the price of evolocumab and its different methods of confirming clinical efficacy, it was necessary to explore its economics and the impact of different methods of confirming efficacy on its economic studies.
Objective: The purpose of this paper was to assess the cost-effectiveness of evolocumab with statins versus statins alone for patients with acute myocardial infarction(AMI) in China and to investigate the impact of different clinical effectiveness modeling approaches on economic outcomes.
Objective: To study chemical constituents of Dendranthema indicum var. aromaticum.
Methods: The constituents were separated and purified by column chromatography with silica gel and Semi-preparative HPLC.
Objective: The chemical components of essential oil from Magnolia biondii were analyzed by GC-MS.
Methods: Essential oil was extracted by steam distillation (SD). The chemical components of essential oil were analyzed by GC-MS.